Marvell expands its board to ten as its $115 billion Lumentum deal sits at a 19.7% spread

On November 11 Marvell's▼−7.21% — Marvell, down 7.21 percent today board voted to expand itself from seven to ten seats, appointing Donna Morris of Walmart▲+1.38% — Walmart, up 1.38 percent today, Douglas Bettinger of Lam Research▼−4.53% — Lam Research, down 4.53 percent today and Sasan Goodarzi of Intuit▼−0.05% — Intuit, down 0.05 percent today, effective November 12, 2026 ¹. The press release↗ cites "an extraordinary period of growth" and never mentions Lumentum▼−6.65% — Lumentum, down 6.65 percent today ¹. Morris is a returning hand: a Marvell director from May 2018 to July 2020 ¹.

The deal the release skips

Nine days earlier, on November 2, Marvell agreed to buy Lumentum for an implied enterprise value of about $115 billion, all stock: 4.5 Marvell shares per Lumentum share, a 23.9% premium to October 28 prices ². Marvell holders keep about 67%, Lumentum holders take about 33%, and closing is expected in the first half of 2028 ². On November 12 the offer was worth about $732.92 per Lumentum share against a $642.09 price, a 19.7% spread, and Marvell owes a $3.2 billion fee if regulators, China's among them, block the deal ³⁴.

Nobody from optics sits in the room

Matt Murphy is chairman and chief executive and keeps both titles under the agreement ². Lumentum's chief executive, Michael Hurlston, and two other Lumentum directors join the board only at closing ².

Until then the three new independents, whose backgrounds are retail human resources, semiconductor-equipment finance and tax software, are the internal check on an optics purchase ¹. AT&S, which builds Marvell's substrate line in Kulim, Malaysia, says that program now totals about $2 billion under long-term customer agreements, with capacity oversubscribed four to five times; its chief executive Michael Mertin drew the layer line plainly: Marvell is substrate and computing, Lumentum "is a laser optics company" ⁶.

The spread answers Murphy's email

Murphy's November 10 staff email↗, filed with the SEC, says Marvell fell about 51% in a month against a 49% average decline for connectivity peers, is still up about 66% year to date, and that major shareholders told him a "very different story" than the analysts ⁵. The spread is the market's louder answer. Lumentum is no distressed seller: its latest quarter brought $1.26 billion of revenue, up 136.5% year over year, against Marvell's record $2.74 billion, up 36.5% ³⁷.

Two deals cleared in five and eight months

The counterpoint is real. On his account the Cavium deal cleared regulators in about seven or eight months and Inphi in five, and Inphi's revenue grew roughly tenfold in five years ⁹. But there is no collar protecting Lumentum holders: every dollar off Marvell's stock cuts $4.50 from the offer, which has already slid from about $1,132 per Lumentum share at the October reference prices to $732.92 ⁸³. The Inference priced the deal near even odds on November 10; the gap has since widened to 19.7% ³.

China signs, or the gap stays

The joint proxy statement is still unfiled, so the November 12 appointments are the last recorded word on who supervises the vote ¹. Marvell reports earnings on December 1, and any regulatory ruling, China's above all, is the gate ³. Until China signs, the 19.7% gap is the market's daily vote on Murphy's record ³.